Quantitative analysis of the human immunodeficiency virus type 1 (HIV- 1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein- Barr virus in late disease
暂无分享,去创建一个
X. Jin | Xia Jin | A. Carmichael | L. Borysiewicz | X Jin | A Carmichael | P Sissons | L Borysiewicz | P. Sissons | Andrew J. Carmichael
[1] M. Kieny,et al. Cytotoxic T lymphocyte response against multiple simian immunodeficiency virusA (SIV) proteins in SIV-infected macaques. , 1992, Journal of immunology.
[2] B. Walker,et al. Identification of overlapping HLA class I-restricted cytotoxic T cell epitopes in a conserved region of the human immunodeficiency virus type 1 envelope glycoprotein: definition of minimum epitopes and analysis of the effects of sequence variation , 1992, The Journal of experimental medicine.
[3] Charles R. M. Bangham,et al. Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition , 1991, Nature.
[4] R. Koup,et al. Limiting dilution analysis of cytotoxic T lymphocytes to human immunodeficiency virus gag antigens in infected persons: in vitro quantitation of effector cell populations with p17 and p24 specificities , 1991, The Journal of experimental medicine.
[5] D. Nixon,et al. Cytotoxic T-cell recognition of HIV proteins and peptides. , 1991, AIDS.
[6] S. Riddell,et al. Cytotoxic T-lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation: pattern of recovery and correlation with cytomegalovirus infection and disease. , 1991, Blood.
[7] D. Watkins,et al. Two distinct lymphocyte populations mediate simian immunodeficiency virus envelope-specific target cell lysis. , 1990, Journal of immunology.
[8] S E Macatonia,et al. Dendritic cell infection, depletion and dysfunction in HIV-infected individuals. , 1990, Immunology.
[9] D. Nixon,et al. High frequency of memory and effector gag specific cytotoxic T lymphocytes in HIV seropositive individuals. , 1990, International immunology.
[10] N. Alp,et al. Automation of limiting dilution cytotoxicity assays. , 1990, Journal of immunological methods.
[11] Andreas Meyerhans,et al. Temporal fluctuations in HIV quasispecies in vivo are not reflected by sequential HIV isolations , 1989, Cell.
[12] B. Guy,et al. Human immunodeficiency virus-specific cytotoxic responses of seropositive individuals: distinct types of effector cells mediate killing of targets expressing gag and env proteins , 1989, Journal of virology.
[13] B. Autran,et al. Unusually high frequencies of HIV-specific cytotoxic T lymphocytes in humans. , 1989, Journal of immunology.
[14] P. Earl,et al. Group-specific, major histocompatibility complex class I-restricted cytotoxic responses to human immunodeficiency virus 1 (HIV-1) envelope proteins by cloned peripheral blood T cells from an HIV-1-infected individual. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[15] I. Stroehmann,et al. Phenotypic heterogeneity of cerebrospinal fluid-derived HIV-specific and HLA-restricted cytotoxic T-cell clones , 1988, Nature.
[16] J. Sissons,et al. Human cytomegalovirus-specific cytotoxic T cells. Relative frequency of stage-specific CTL recognizing the 72-kD immediate early protein and glycoprotein B expressed by recombinant vaccinia viruses , 1988, The Journal of experimental medicine.
[17] E. Engleman,et al. Activation of HLA-restricted EBV-specific cytotoxic T cells does not require CD4+ (helper) T cells or exogenous cytokines. , 1988, Journal of immunology.
[18] J. Sissons,et al. Human cytomegalovirus‐specific cytotoxic T cells: their precursor frequency and stage specificity , 1988, European journal of immunology.
[19] U. Koszinowski,et al. CD8-positive T lymphocytes specific for murine cytomegalovirus immediate-early antigens mediate protective immunity , 1987, Journal of virology.
[20] J. Levy,et al. CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication. , 1986, Science.
[21] A. McMichael,et al. Cytotoxic T-cell immunity to influenza. , 1983, The New England journal of medicine.
[22] Y. L. Lin,et al. Biological properties of an influenza A virus-specific killer T cell clone. Inhibition of virus replication in vivo and induction of delayed- type hypersensitivity reactions , 1981, The Journal of experimental medicine.
[23] Ra Thompson,et al. Limiting Dilution Analysis of Cells in the Immune System , 1980 .
[24] Ryser Je,et al. Limiting Dilution Analysis of Alloantigen-Reactive T Lymphocytes I. Comparison of Precursor Frequencies for Proliferative and Cytolytic Responses , 1979 .
[25] D. Wilson,et al. Histocompatibility antigen-activated cytotoxic T lymphocytes. II. Estimates of the frequency and specificity of precursors , 1977, The Journal of experimental medicine.
[26] B. Autran,et al. Carboxyl-terminal and central regions of human immunodeficiency virus-1 NEF recognized by cytotoxic T lymphocytes from lymphoid organs. An in vitro limiting dilution analysis. , 1992, The Journal of clinical investigation.
[27] H. Macdonald,et al. Limiting dilution analysis of alloantigen-reactive T lymphocytes. I. Comparison of precursor frequencies for proliferative and cytolytic responses. , 1979, Journal of immunology.